Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06522334Recruiting

Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria

Role: lead

NCT01727518Active Not Recruiting

The Austrian LEAD (Lung hEart sociAl boDy) Study

Role: lead

NCT06522347Recruiting

Mycobacteria Registry Study: Prospective Observational Study in Austria

Role: lead

NCT04346264Completed

CoVid-19 - Infection and Antibody Formation in the Viennese Population

Role: lead

All 4 trials loaded